首页> 外国专利> The somatotropin formulation of improved syringeability

The somatotropin formulation of improved syringeability

机译:改善可注射性的生长激素制剂

摘要

PURPOSE: A somatotropin composition having improved syringeability is prepared by mixing somatotropin and at least one kind of fat soluble vitamin and adding bioacceptable surfactant thereto. CONSTITUTION: The somatotropin composition consists of somatotropin displaying activity in a living body, at least one kind of fat soluble vitamin such as vitamin A and E, and pharmaceutically acceptable surfactant. Therefore it shows superior syringeability than conventional somatotropin formulations even at low and room temperature. In particular, the composition contains 10-50 wt.% of somatotropin based on total composition, 100000-5000000, preferably 300000-3500000 units of vitamin A per 1g of somatotropin, and 500-12000, preferably 1500-8500 units of vitamin E per 1g of somatotropin. Also it contains 0.5-25, preferably 1-15 wt.% of pharmaceutically acceptable surfactant based on total composition.
机译:目的:通过将生长激素和至少一种脂溶性维生素混合并向其中添加生物可接受的表面活性剂来制备具有改善的可注射性的生长激素组合物。组成:生长激素组合物由在生物体内显示活性的生长激素,至少一种脂溶性维生素(例如维生素A和E)和可药用表面活性剂组成。因此,即使在低温和室温下,它也显示出比常规生长激素制剂优越的可注射性。特别地,组合物包含基于总组合物的10-50重量%的生长激素,每1g生长激素100000-5000000,优选300000-3500000单位的维生素A,和每500g 2000-1500,优选1500-8500单位的维生素E。 1g生长激素。还包含基于总组合物的0.5-25重量%,优选1-15重量%的药学上可接受的表面活性剂。

著录项

  • 公开/公告号KR20010089862A

    专利类型

  • 公开/公告日2001-10-12

    原文格式PDF

  • 申请/专利权人 LG CHEM INVESTMENT LTD.;

    申请/专利号KR20000015091

  • 发明设计人 KIM NAM JUNG;RYU JE PIL;

    申请日2000-03-24

  • 分类号A61K38/27;

  • 国家 KR

  • 入库时间 2022-08-22 01:12:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号